Sep 5, 2020

Using CRISPR to improve viral vectors for gene therapy

Posted by in category: biotech/medical

To overcome preexisting immunity that cripples the adenovirus vectors used in gene therapy and vaccines, scientists at the University of Pittsburgh created a CRISPR-based system that briefly suppresses the genes that cause the problem. The method improved gene therapy uptake in mice and is being developed by startup SafeGen.

Leave a reply